Monday, June 15, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 318 of 1,261
  1. US 11104689

    Influenza virus replication inhibitor and use thereof

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Aug 31, 2021 · Expires Aug 26, 2041

    granted
  2. US 11103472

    Oral suspensions comprising a non-steroidal anti-inflammatory drug (NSAID)

    Infirst Healthcare Limited · Granted Aug 31, 2021 · Expires Aug 26, 2041

    granted
  3. US 11104719

    Recombinant clusterin and use thereof in the treatment and prevention of disease

    The Board of Regents of the University of Texas System · Granted Aug 31, 2021 · Expires Aug 26, 2041

    granted
  4. US 11103454

    Wax foamable vehicle and pharmaceutical compositions thereof

    Vyne Therapeutics Inc. · Granted Aug 31, 2021 · Expires Aug 26, 2041

    granted
  5. US 11103462

    Protein nanocapsules with detachable zwitterionic coating for protein delivery

    The Regents of the University of California · Granted Aug 31, 2021 · Expires Aug 26, 2041

    granted
  6. US 11103460

    Fabrication methods for nanodelivery systems for long term controlled delivery of active pharmaceutical ingredients

    The Board of Regents of the University of Texas System · Granted Aug 31, 2021 · Expires Aug 26, 2041

    granted
  7. US 11102961

    Non-human animals having a humanized lymphocyte-activation gene 3

    REGENERON PHARMACEUTICALS, INC. · Granted Aug 31, 2021 · Expires Aug 26, 2041

    granted
  8. US 11103436

    Peptide exhibiting wrinkle-improving activity and uses thereof

    CAREGEN CO., LTD. · Granted Aug 31, 2021 · Expires Aug 26, 2041

    granted
  9. US 11104918

    Universal donor cells

    CRISPR THERAPEUTICS AG · Granted Aug 31, 2021 · Expires Aug 26, 2041

    granted
  10. US 11104737

    ACVR2A-specific antibody and method of treatment of muscle atrophy

    Rigel Pharmaceuticals, Inc. · Granted Aug 31, 2021 · Expires Aug 26, 2041

    granted
  11. US 11104730

    Methods of treating eye disorders with APLNR antagonists and VEGF inhibitors

    REGENERON PHARMACEUTICALS, INC. · Granted Aug 31, 2021 · Expires Aug 26, 2041

    granted
  12. US 11104729

    Anti-IL-33 antibodies and uses thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Aug 31, 2021 · Expires Aug 26, 2041

    granted
  13. US 11104901

    Brush polymer-assisted compaction of oligonucleotides

    Northwestern University · Granted Aug 31, 2021 · Expires Aug 26, 2041

    granted
  14. US 11104715

    Methods for producing aflibercept in chemically defined media having reduced aflibercept variants

    REGENERON PHARMACEUTICALS, INC. · Granted Aug 31, 2021 · Expires Aug 26, 2041

    granted
  15. US 11104708

    Articles comprising a silk polypeptide for antigen delivery

    Ludwig-Maximilians-Universitat Munchen · Granted Aug 31, 2021 · Expires Aug 26, 2041

    granted
  16. US 11104706

    Ang (1-7) derivative oligopeptides and methods for using and producing the same

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Aug 31, 2021 · Expires Aug 26, 2041

    granted
  17. US 11104957

    Compositions and methods for treating cancers

    APTOSE BIOSCIENCES INC. · Granted Aug 31, 2021 · Expires Aug 26, 2041

    granted
  18. US 11104712

    Methods for modulating an immune response

    Cue Biopharma, Inc. · Granted Aug 31, 2021 · Expires Aug 26, 2041

    granted
  19. US 11104704

    Peptide having cytoprotective effect against environmental pollutant and use thereof

    CAREGEN CO., LTD. · Granted Aug 31, 2021 · Expires Aug 26, 2041

    granted
  20. US 11104660

    PDE4D inhibitors

    Tetra Discovery Partners · Granted Aug 31, 2021 · Expires Aug 26, 2041

    granted
  21. US 11103601

    Lymph targeting nuclear magnetic contrast agent using brown algae polysaccharide as carrier and preparation method and use thereof

    OCEAN UNIVERSITY OF CHINA · Granted Aug 31, 2021 · Expires Aug 26, 2041

    granted
  22. US 11103622

    Thromboresistant/bactericidal s-nitroso-n-acetylpenicillamine (SNAP)-doped nitric oxide release polymers with enhanced stability

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Aug 31, 2021 · Expires Aug 26, 2041

    granted
  23. US 11103591

    Bicyclic peptide ligands specific for MT1-MMP

    BicycleRD Limited · Granted Aug 31, 2021 · Expires Aug 26, 2041

    granted
  24. US 11103581

    Methods and compositions for self-regulated release of active pharmaceutical ingredient

    Acurx Pharmaceuticals, Inc. · Granted Aug 31, 2021 · Expires Aug 26, 2041

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.